Following after are RSV vaccines from Johnson & Johnson as well ... It will compete with Sobi's Synagis (palivizumab), an antibody originated by AZ, which is dosed once a month.

As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, with health experts warning ...

Synagis is a former blockbuster – first approved ... However, revenues from the antibody are expected to drop sharply once Beyfortus and vaccines for RSV prevention enter the market.

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw ...

While Robert F. Kennedy Jr., President Donald Trump’s pick to lead the US Department of Health and Human Services, has backpedaled on his anti-vaccine rhetoric during his Senate confirmation ...

Diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant) and inactivated poliovirus vaccine combined Pediarix (GlaxoSmithKline) 24 hr Manufacturer Diphtheria and ...

24, 2025 — A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical ...

The development and use of aquatic vaccines are the safest and most effective ways to prevent aquatic animal diseases and preserve the health and sustainability of aquaculture. To give references for ...

After hours: 7:29:01 pm GMT-5 ...